Status:
RECRUITING
Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects
Lead Sponsor:
Centre Hospitalier Universitaire de la Guadeloupe
Conditions:
s100b
Eligibility:
All Genders
18-65 years
Brief Summary
Numerous studies have demonstrated the significant contribution of S100B blood level measurement in the management of minor to moderate traumatic brain injuries, notably by reducing the number of cran...
Detailed Description
Thanks to its excellent negative predictive value, the S100B protein has been defined as a reliable alternative to computed tomography (CT) in the management of traumatic brain injury (TBI). Validated...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Hospital staff of the University Hospital of Guadeloupe or the Hospital of Basse-Terre
- Age between 18 and 65 years
- Individuals willing to specify their ethnic origin and skin phototype
- Individuals affiliated with or beneficiaries of a social security scheme
- Informed individuals who have given their voluntary, informed, and written consent
- Exclusion Criteria :
- Individuals on anticoagulant therapy
- Individuals with a personal history of neurological disease
- Individuals with a personal history of melanoma
- Refusal to participate
- Individuals under guardianship, curatorship, or legal protection
Exclusion
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06998381
Start Date
February 1 2023
End Date
August 1 2025
Last Update
May 31 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de la Basse-Terre
Basse-Terre, Guadeloupe, 97109
2
Chu de La Guadeloupe
Pointe-à-Pitre, Guadeloupe, 97159